Gastroenterology & Hepatology

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  

Division of Gastroenterology & Hepatology
Inflammatory Bowel Disease Program


A specialty area of the Division of Gastroenterology and Hepatology is the treatment of Inflammatory Bowel Disease (IBD). Crohn´s Disease and ulcerative colitis are the two major forms of IBD. IBD is estimated to afflict more than one million Americans, with over 30,000 new cases being diagnosed each year. An estimated 100,000 children suffer from IBD. Symptoms of IBD include persistent diarrhea, abdominal pain, lethargy, rectal bleeding, weight loss, fever, and delayed growth. Long-term complications may include intestinal ulceration, scarring, and bowel obstruction that may require intestinal surgery. Currently there is no known cure for these diseases.

Specialists in the Inflammatory Bowel Disease Program are researching cellular and molecular mechanisms that underlie intestinal inflammation and understand the importance of finding new treatments for inflammatory disorders of the intestine. In addition the IBD team is involved in multiple clinical trials evaluating new forms of therapy for IBD patients.

The IBD Program at Froedtert oversees 500 patients each year, making it the leading IBD program in southeastern Wisconsin. What we learn from patient care today will influence and improve future medical treatments for IBD patients.

The treatment of Crohn's disease and ulcerative colitis is directed toward reducing or eliminating inflammation.  Maintenance therapy, emphasized in the IBD Program is focused on reducing relapses by identifying risk factors and tailoring the use of medications.  In the past several years, drug treatments for IBD have improved and physicians have learned more about programming  certain treatment schedules.  The Froedtert IBD Program has been involved in several new treatment studies that have proven effective in the treatment of IBD. 

The combined efforts of researchers, clinicians, and patients working together in the IBD Program is a partnership in search of improved treatment and potential cure for the disease.

Faculty & Providers:

Dilpesh Agrawal, MD

Daniel Stein, MD

Kari Best, PA-C

Katie Idstein, PA-C


Resource: Crohn's & Colitis Foundation of America
© 2014 Medical College of Wisconsin
Page Updated 10/02/2014